Skip to content
10-Q

Quarterly Report

RVL Pharmaceuticals plc

0001558370-23-014733

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 11, 2023 99.54M sh
Shares Diluted Q2 2023 · Jun 30, 2023 99.37M sh
Shares Diluted Q2 2023 · Jun 30, 2023 99.35M sh
Shares Diluted Q2 2023 · Jun 30, 2022 83.58M sh
Shares Diluted Q2 2023 · Jun 30, 2022 83.54M sh
Capex Q2 2023 · Jun 30, 2023 $2.35M
Capex Q2 2023 · Jun 30, 2022 $27K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$17.88M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$11.28M
Long Term Debt Q2 2023 · Jun 30, 2023 $63.6M
Short Term Debt Q2 2023 · Jun 30, 2023 $57.75M
Short Term Debt Q2 2023 · Dec 31, 2022 $1.43M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $19.16M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $44.54M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $27.41M
Cash And Equivalents Q2 2023 · Dec 31, 2021 $40.44M
Stockholders Equity Q2 2023 · Jun 30, 2023 $16.33M
Stockholders Equity Q2 2023 · Mar 31, 2023 $40M
Stockholders Equity Q2 2023 · Dec 31, 2022 $51.09M
Stockholders Equity Q2 2023 · Jun 30, 2022 $58.51M
Stockholders Equity Q2 2023 · Mar 31, 2022 $69.48M
Stockholders Equity Q2 2023 · Dec 31, 2021 $76.73M
Current Liabilities Q2 2023 · Jun 30, 2023 $68.39M
Current Liabilities Q2 2023 · Dec 31, 2022 $19.72M
Total Liabilities Q2 2023 · Jun 30, 2023 $69.08M
Total Liabilities Q2 2023 · Dec 31, 2022 $77.42M
Current Assets Q2 2023 · Jun 30, 2023 $25.75M
Current Assets Q2 2023 · Dec 31, 2022 $56.98M
Total Assets Q2 2023 · Jun 30, 2023 $85.4M
Total Assets Q2 2023 · Dec 31, 2022 $128.51M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.24
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.36
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.14
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.23
Eps Basic Q2 2023 · Jun 30, 2023 −$0.24
Eps Basic Q2 2023 · Jun 30, 2023 −$0.36
Eps Basic Q2 2023 · Jun 30, 2022 −$0.14
Eps Basic Q2 2023 · Jun 30, 2022 −$0.23
Sga Expense Q2 2023 · Jun 30, 2023 $13.89M
Sga Expense Q2 2023 · Jun 30, 2023 $30.08M
Sga Expense Q2 2023 · Jun 30, 2022 $20.17M
Sga Expense Q2 2023 · Jun 30, 2022 $44M
Rd Expense Q2 2023 · Jun 30, 2023 $547K
Rd Expense Q2 2023 · Jun 30, 2023 $1.17M
Rd Expense Q2 2023 · Jun 30, 2022 $1.18M
Rd Expense Q2 2023 · Jun 30, 2022 $2.04M
Net Income Q2 2023 · Jun 30, 2023 −$23.89M
Net Income Q2 2023 · Jun 30, 2023 −$35.5M
Net Income Q2 2023 · Jun 30, 2022 −$12.11M
Net Income Q2 2023 · Jun 30, 2022 −$18.93M
Operating Income Q2 2023 · Jun 30, 2023 −$22.02M
Operating Income Q2 2023 · Jun 30, 2023 −$32.31M
Operating Income Q2 2023 · Jun 30, 2022 −$15.12M
Operating Income Q2 2023 · Jun 30, 2022 −$20.52M
Gross Profit Q2 2023 · Jun 30, 2023 $6.31M
Gross Profit Q2 2023 · Jun 30, 2023 $12.85M
Gross Profit Q2 2023 · Jun 30, 2022 $6.22M
Gross Profit Q2 2023 · Jun 30, 2022 $25.52M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $1.95M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $4.25M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $2.23M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $4.37M
Revenue Q2 2023 · Jun 30, 2023 $8.26M
Revenue Q2 2023 · Jun 30, 2023 $17.09M
Revenue Q2 2023 · Jun 30, 2022 $8.45M
Revenue Q2 2023 · Jun 30, 2022 $29.89M